LIBMAN-SACKS ENDOCARDITIS IN A SYSTEMIC LUPUS ERYTHEMATOSUS MALE PATIENT

Authors

  • Fauqa Arinil Aulia Department of Clinical Pathology Faculty of Medicine Airlangga University Surabaya
  • Sidarti Soehita

DOI:

https://doi.org/10.24293/ijcpml.v25i3.1358

Keywords:

Libman-Sacks endocarditis, Systemic Lupus Erythematosus, complement level, valve vegetation

Abstract

Libman-Sacks endocarditis (verrucous vegetations, marantic, or nonbacterial thrombotic endocarditis) is a rare cardiac manifestation in SLE. The objective was to describe Libman-Sacks endocarditis in a SLE male patient. A 21-year-old male was admitted to the hospital with shortness of breath, epigastric pain, oral ulcer, discoid lesions, and knee joints pain since 3 months before. He worked as a paper mill employee and was exposed to instruments radiating UV rays for 2 years. Antibiotics initiation was given due to an infective endocarditis suspicion. Vital signs were as follows: temperature 37oC, heart rate 110beats/minute, respiratory rate 30breaths/minute, blood pressure 100/80mmHg, and SaO2 99% with nasal oxygenation. Cardiac examination showed regular rate and rhythm with diastolic murmur at left ICS III and upper left sternal border. Lower extremities showed pitting edema. Laboratory results: hemoglobin 9.6g/dl, RBC 3.6x106/μl, hematocrit 30.8%, WBC 0.88x103/μl, platelet count 22x103/μl, BUN 74.0mg/dl, serum creatinine 1.6mg/dl, ESR 24mm/h, CRP 1.2mg/dl, C3 <16.4mg/dl, C4 8mg/dL, ANA test indeterminate (23.84), and anti dsDNA negative (7.4WHOunits/mL). Chest X-Ray showed mitral heart configuration with right ventricle and left atrium enlargement, pneumonia, and right pleural effusion. ECG showed normal sinus rhythm, left ventricular hypertrophy with repolarization abnormality, and prolonged QT wave. A 2-D echocardiogram showed an evidence of vegetation on aortic and pulmonary valve. Based on the American College of Rheumatology SLE Criteria, low complement level, and evidence of vegetation on aortic and pulmonary valve, the patient was diagnosed as Libman-Sacks Endocarditis. The diagnosis should be confirmed by antiphospholipid antibodies examination.

 

Downloads

Download data is not yet available.

References

Libman E and Sacks BA. Undescribed Form of Valvular and Mural Endocarditis. Arch Intern Med, 1924, 33: 701-737.

Moyssakis I, Tektonidou MG, Vassilliou VA, Samarkos M, Votteas V, et al. Libman-Sacks endocarditis in systemic lupus erythematosus: prevalence, associations, and evolution. Am J Med. 2007;120:636–42.

Ruiz-Irastorza G and Khamashta M. Cardiopulmonary Disease in SLE. Dubois' Lupus Erythematosus and Related Syndromes 8th ed. 2012, 352-362.

Salvador MT and Navarra SV. Infective Versus Libman Sacks Endocarditis In Systemic Lupus Erythematosus. Salvador and Navarra, Rheumatol Curr Res 2013, S16.

Keogan MT, Wallace EM, and O'Leary P. Connective Tissue Disease in Concise Clinical Immunology for Healthcare Professionals. New York, USA, 2006: Routledge, page 211.

Aranow C, Diamond B, and Mackay M. Systemic lupus erythematosus in Clinical Immunology: Principle and Practice Third Edition. China, 2008: Elsevier.

Menard GE. Establishing the Diagnosis of Libman–Sacks Endocarditis in Systemic Lupus Erythematosus. J Gen Intern Med, 2008, 23(6):883–6.

Du Clos TW and Mold C. Complement and Complement Deficiencies in Clinical Immunology: Principle and Practice Third Edition. China, 2008: Elsevier.

Greidinger EL and Hoffman RW. Antinuclear Antibody Testing: Methods, Indications, and Interpretation. Laboratory medicine, February 2003, number 2, volume 34.

Ho A, Magder LS, Barr SG, and Petri M. Decreases in anti–double"stranded DNA levels are associated with concurrent flares in patients with systemic lupus erythematosus. Arthritis and Rheumatology, 2001, Volume 44 Issue 10, pages 2342 – 2349.

Downloads

Submitted

2018-11-16

Accepted

2019-01-25

Published

2019-04-13

How to Cite

[1]
Aulia, F.A. and Soehita, S. 2019. LIBMAN-SACKS ENDOCARDITIS IN A SYSTEMIC LUPUS ERYTHEMATOSUS MALE PATIENT. INDONESIAN JOURNAL OF CLINICAL PATHOLOGY AND MEDICAL LABORATORY. 25, 3 (Apr. 2019), 372–378. DOI:https://doi.org/10.24293/ijcpml.v25i3.1358.

Issue

Section

Case Report